We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (257)
- Legislation (84)
- COVID-19 (66)
- Compliance and enforcement (51)
- Vaping hub (46)
- Manufacturing (29)
- Import and export (22)
- Labelling and packaging (20)
- Medicinal cannabis hub (20)
- Scheduling (national classification system) (19)
- Safety monitoring and information (13)
- Weight loss products (6)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Committees and advisory bodies (2)
- Prescription opioids hub (2)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (2)
- Clinical trials (1)
- Fees and payments (1)
- Urogynaecological (transvaginal) surgical mesh hub (1)
Search
712 result(s) found, displaying 401 to 425
-
Media releasesThe TGA, part of the Department of Health, has granted provisional determination to Moderna Australia Pty Ltd in relation to the COVID-19 Vaccine, Elasomeran
-
Media releasesInteraction between TGA and AHPRA advertising guidelines
-
Media releasesThe TGA has issued two infringement notices totalling $26,640 to Sydney company Aidacare Pty Ltd (Aidacare).
-
Media releasesThe TGA is seriously concerned about misleading information that has been broadcast on radio stations providing a distorted picture of the safety of COVID-19 vaccines.
-
Media releasesThe TGA has implemented arrangements to facilitate the communication of information about approved COVID-19 vaccines.
-
Media releasesThe TGA has issued three infringement notices to a Queensland man for the alleged unlawful importation of a medicine containing Armodafinil.
-
Media releasesThe TGA has issued two infringement notices to a dentist from Western Australia for the alleged unlawful importation of cosmetic injectables.
-
Media releasesThe TGA has issued two infringement notices to Perth-based company V P & Associates Pty Ltd (V P & Associates), for alleged unlawful advertising of a medical device in relation to SARS-CoV-2 Human Coronavirus.
-
Regulatory decision noticesDirection Notice issued to cease advertising of therapeutic goods not entered in the ARTG
-
Media releasesThe TGA is warning sponsors not to advertise listed medicines that are not included in the ARTG with permitted indications
-
Media releasesPeter Evans Chef Pty Ltd fined $79,920 for alleged unlawful advertising
-
Media releasesThe infringement notice relate to the alleged failure to provide information on a contact person responsible for medicine safety.
-
Media releasesGlobal Therapeutics Pty Ltd has paid penalties of $119,880 in response to nine infringement notices
-
Media releasesUpdated safety advisory - rare and unusual blood clotting syndrome (thrombosis with thrombocytopenia)
-
Media releasesTGA has recently approved wider storage and transportation conditions for the Pfizer COVID-19 vaccine in Australia
-
Media releasesThe TGA is investigating the advertising of stem cell therapies to ensure that content in the public domain complies with the Australian rules for advertising therapeutic goods.
-
Media releasesSome rare cases of thrombosis associated with thrombocytopenia have been reported overseas following the administration of COVID-19 Vaccine AstraZeneca.
-
Media releasesAustralia’s vaccine safety and regulatory process is world class and people can be confident that vaccines approved for use are safe and effective.
-
Regulatory decision noticesNew legislative instrument
-
Media releasesIt is alleged the company breached the Therapeutic Goods Act 1989 in relation to the importation of surgical face masks.
-
Media releasesTGA has issued two infringement notices for alleged unlawful advertising of a complementary medicine cancelled from the Australian Register of Therapeutic Goods.
-
Media releasesTGA has issued four infringement notices for alleged unlawful advertising of a complementary medicine.
-
Media releasesThe Melbourne-manufactured AstraZeneca vaccine is now available for Australians, with the TGA this evening approving the release of the first four batches.
-
Media releasesTGA has approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia.
-
Media releasesTGA issued a fine for alleged advertising of an unlisted complementary medicine after Junction Rx failed to comply with a cease and desist notice by the set deadline.